Is 1P-LSD legal in New Zealand?

Legal status

Controlled through the open analogue limb rather than by a schedule name. 1P-LSD, a lysergamide sold as a propionyl form of LSD, has no entry of its own in Schedules 1 to 3 on the text cited, and this finding does not rest on that absence: the Misuse of Drugs Act 1975 defines a controlled drug analogue as any substance whose structure is substantially similar to that of a controlled drug, subject to the stated exclusions, and the stated parent structure places 1P-LSD in that limb unless a medicine exclusion or an express exclusion applies. The analogue route lands in Schedule 3 Part 7, so the class is C. LSD itself has its own row in this table and sits in Schedule 1 as Class A, so the parent is named while this molecule is reached only through the analogue limb, and the two therefore carry different ceilings. The dossier states the statutory route rather than claiming a laboratory determination, because a court-grade analogue conclusion can depend on expert structural evidence. The reading is against the Misuse of Drugs Act 1975 consolidation current at 20 September 2026, whose latest commenced classification instrument is the Misuse of Drugs (Classification and Presumption of Supply) Order 2025, in force from 27 November 2025.

Consequences if caught

Capital exposure: none. New Zealand has no death penalty. A controlled drug analogue is treated as a Class C controlled drug, so the exposure on 1P-LSD is the section 6 dealing maximum of 8 years, with section 7 reaching possession. This row's own ceiling column states the section 7 limb without attaching a figure to it, and the Class C rows in this table put that possession maximum at 3 months. The 8 year figure is the whole of the exposure on this route. The route runs through similarity to a compound that carries a life ceiling, so the gap between this row and the LSD row is the most important number on it.

If prescribed or medical

Not established for a traveller. This dossier carries no country-level rule for entering New Zealand with a prescribed medicine: it records that medicines status has to be checked alongside the analogue exclusions and the Psychoactive Substances Act 2013 route, and that a court-grade conclusion can turn on the medicine exclusions, but it states no declaration requirement, no permit, no quantity allowance and no carry limit at the border, and none was researched for this cell. What is established is the placement a traveller would be read against: 1P-LSD is not named in Schedules 1 to 3 and is reached, if at all, through the section 2 controlled-drug-analogue limb, which is treated as Class C. No dispensed form exists, so the question here is whether a blotter sheet is an analogue, not whether a prescription covers it. Do not read that placement as a ruling on a lawfully prescribed and lawfully carried supply, which is a different question this cell does not answer. Settle the border question with the Ministry of Health, whose classification order implementation page this dossier cites, and with the New Zealand border authority, before travelling.

Documentation

Carry the Misuse of Drugs Act 1975 consolidation current at 20 September 2026 and read section 2 together with Schedule 3 Part 7, because neither carries the finding for 1P-LSD on its own. Read the section 2 analogue definition beside the Schedule 1 LSD entry, because the whole finding for 1P-LSD turns on the relationship between the two. Carry the point that an absent name is not an answer in New Zealand: the list is closed for named substances while the analogue limb is open, so a search of the schedules that returns nothing has not finished the question. Carry the classification chain this finding was read against as well: the 2022 and 2025 Classification and Presumption of Supply Orders with their commencement orders, the 2024 pseudoephedrine amendment, and the 2026 Order, which was made but is not treated as law in this dossier because its own section 2 leaves commencement to the Governor-General and no commencement instrument was located by the horizon. Carry the date as well, 20 September 2026, because in New Zealand a classification order can move a substance between classes without a word of the Act changing.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.